BGPT: Paper Review: Genetics of human isolated acromesomelic dysplasia

Explore by Goal

Quick Explanation Copied

Evidence summary (skeptical)

This paper is primarily a literature review tying isolated acromesomelic dysplasia (AMD) types to GDF5/BMPR1B (Grebe- and Hunter–Thompson types) and NPR2 (Maroteaux type), while summarizing clinical/radiographic patterns and known mutations reported across families.

Core gene-to-type linkage:

Long Explanation

Paper Review (Critical): Genetics of human isolated acromesomelic dysplasia

Primary source: 10.1016/j.ejmg.2016.02.011 Publication date: 27 Feb 2016 (as stated in the provided full text)

Visual map: AMD types → genes → signal axis

Gene-to-type framing is taken directly from the paper’s review claims.

Mutation classes cataloged in the review tables

Using the provided full text tables for the named mutations in GDF5 (AMDG) and NPR2 (AMDM). BMPR1B specific variants are present but not fully enumerated as machine-readable rows in the provided extraction; so this chart focuses on the explicit rows we can reliably parse from the text you provided.

The tallies above are limited to explicitly shown mutation labels in the provided full-text snippet; they do not represent a complete global census of all known AMD variants.

Evidence strength view: review vs. primary genetics

The review’s claims are strengthened when they align with primary genetic studies (co-segregation, linkage, functional assays), and weakened when they rely primarily on narrative linkage without new data.

This graph is a methodological heuristic to help interpret the review; it is not a quantitative result from the paper.

What the paper actually does (scope & structure)

The article is explicitly a review describing clinical spectrum, genetics, and “signalopathies” for isolated acromesomelic dysplasia, emphasizing an autosomal recessive segregation pattern and summarizing known gene involvement.
It groups isolated forms into:

AMDG + AMDH → GDF5–BMPR1B signalopathy

AMDM → CNP–NPR2 signalopathy (NPR2)

Gene-to-phenotype claims: where they are strong vs. speculative

1) Core linkage for AMDG/AMDH (GDF5 ↔ BMPR1B axis)

The review states that Grebe-type (AMDG) involves pathogenic sequence variations in GDF5 and mutations in BMPR1B, and that AMDG and AMDH share the same GDF5–BMPR1B signaling framework.

Consistency check with primary genetics (example): A study in a consanguineous Pakistani context reports novel homozygous truncating GDF5 variants underlying Grebe-type acromesomelic dysplasia type grebe (AMDG) and uses linkage + sequencing + population-frequency filtering and in silico modeling.

2) Core linkage for AMDM (NPR2)

The review attributes Maroteaux-type (AMDM) to mutations in NPR2 and describes impaired CNP/NPR2→cGMP signaling as mechanistically relevant to endochondral ossification and growth.

Consistency check with primary genetics (example): A human genetics paper identifies mutations in NPR-B (NPR2) impairing skeletal growth and causing acromesomelic dysplasia type Maroteaux.

Note: I cannot properly cite Bartels et al. (2004) in the required format because the DOI is not present in the provided content. Therefore, the AMDM mechanistic section remains supported primarily by the review itself in this output.

3) Signalopathy framing (“GDF5–BMPR1B” and “CNP–NPR2”)

The paper’s “signalopathy” framing is conceptually useful for clustering phenotypes, but it is a model (pathway abstraction), not a directly measured causal mechanism for each individual patient. The review does not appear (in the provided text) to add new pathway perturbation experiments for AMD specifically; it summarizes earlier signaling knowledge.

Blindspots / limitations I see (critical, evidence-based)

Review-level risk: conclusions about “signalopathies” are only as strong as the cited primary literature; reviews can reproduce biases (e.g., concentration of reports in certain populations, selection toward consanguinity cohorts) unless they systematically assess variant discovery and sampling.
Orthology/translation caveat: the review discusses pathway roles using general developmental signaling and animal models; cross-species mechanistic mapping can be incomplete when receptor-ligand context differs. (I am flagging this as a general methodological blindspot; the review text provided here does not quantify this uncertainty.)
Variant spectrum incompleteness: the provided mutation inventory focuses on listed variants; it does not guarantee that “only three genes cause isolated AMD” for all cases, especially if some variants lie outside coding regions or are missed by ascertainment pipelines. The review itself states that additional genes may emerge.

At-a-glance: phenotypic discriminators emphasized

AMD type	Pattern emphasis (from provided text)	Reported gene axis
AMDG (Grebe)	Severe acromesomelia / limb shortening; distal emphasis; facial/intelligence/vertebral abnormalities reported as absent in the review’s discussion of AMDG	GDF5 & BMPR1B
AMDH (Hunter–Thompson)	Lower limbs more affected; craniofacial and axial skeleton normal per review table/discussion	GDF5 & BMPR1B
AMDM (Maroteaux)	Axial involvement (vertebral wedging) differs from AMDG/AMDH; mid-distal appendicular shortening emphasized	NPR2

Selected external primary genetics anchor (for AMDG)

GDF5 truncating variants → AMDG in a primary family study

A primary study reports two novel homozygous truncating GDF5 variants in two consanguineous families, absent in obligate carriers and 150 matched controls, supporting loss-of-function as a causal mechanism for AMDG.

Because the provided bibliography snippet in your prompt does not include DOIs for many cited foundational papers, I can only “fully DOI-cite” a subset of the primary evidence here.

Go deeper in BGPT (bespoke queries)

Run a fully-independent agent (optional)

This will iteratively extract, cross-check, and synthesize gene↔phenotype evidence using the provided paper text and the linked primary studies available.

Author reviews (BGPT links)

Feedback:

Updated: April 21, 2026